Persistent URL of this record https://hdl.handle.net/1887/107048
In Collections
This item can be found in the following collections:
![Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
- All authors
- Heijde, D. van der; Braun, J.; Rudwaleit, M.; Purcaru, O.; Kavanaugh, A.
- Date
- 2012-10-31
- Journal
- Arthritis and Rheumatism
- Volume
- 64
- Issue
- 10
- Pages
- S592 - S592